View More Recent Stories
-
ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2016 Financial Results and Reaffirm Guidance
-
ANI Pharma (ANIP) Names Stephen P. Carey as CFO
-
ANI Announces Appointment of Stephen P. Carey as Vice President and Chief Financial Officer
-
ANI Pharma (ANIP) Announces FDA Approval of Oxycodone HCl Caps ANDA
-
ANI Pharmaceuticals Announces FDA Approval of Oxycodone Capsules, 5mg
-
ANI Pharma (ANIP) Announces Hydrocortisone Rectal Cream 1% and 2.5% Commercially Launches
-
ANI Pharmaceuticals Announces Launch of Hydrocortisone Rectal Cream 1% and 2.5%
-
ANI Pharma (ANIP) Updates FY16 Outlook Following Acquisition of Cranford Pharma's Inderal LA Assets
-
ANI Pharmaceuticals Updates 2016 Financial Guidance
-
ANI Pharmaceuticals Closes Acquisition of InderalĀ® LA Assets
-
ANI Pharma (ANIP) to Acquire Inderal LA Asset Portfolio from Cranford Pharma
-
ANI Pharmaceuticals Agrees to Acquire InderalĀ® LA Assets from Cranford Pharmaceuticals
-
ANI Pharmaceuticals to Present at 28th Annual ROTH Conference
-
ANI Pharma (ANIP) and Partner Dexcel Reprot FDA Approval of Donepezil Hydrochloride 23mg Tablets
-
ANI Pharmaceuticals and Dexcel Announce FDA Approval of Donepezil Hydrochloride 23mg Tablets
-
ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Results and Provides 2016 Guidance
-
ANI Pharma (ANIP) Announces Receipt of Exclusive Generic Lipofen Distribution Rights
-
ANI Pharmaceuticals Acquires Exclusive Rights to Distribute Three Generic Drug Products from H2-Pharma for $10 Million
-
ANI Pharma (ANIP) Closes $75M NDA Acquisition from Merck
-
ANI Pharmaceuticals Closes Transaction to Acquire Two NDAs from Merck for $75 Million
-
ANI Pharma (ANIP) Launches Flecainide Acetate Tabs
-
ANI Pharmaceuticals Announces Launch of Flecainide Tablets
-
ANI Pharma (ANIP) Launches Nimodipine 30mg Capsules
-
ANI Pharmaceuticals Announces Launch of Nimodipine 30mg Capsules
-
ANI Pharma (ANIP) Receives FDA Approval for Polyethylene Glycol 3350 Powder for Oral Solution ANDA
-
ANI Pharmaceuticals Announces FDA Approval of Polyethylene Glycol 3350 Powder for Oral Solution, 17mg/Scoopful
-
ANI Pharmaceuticals Presents At Oppenheimer 26th Annual Healthcare Conference
-
ANI Pharmaceuticals Reports Third Quarter and Year-To-Date 2015 Results and Highlights
-
ANI Pharmaceuticals Announces Launch of Vancomycin Capsules
-
ANI Pharmaceuticals Announces Launch of Oxycodone Hydrochloride Oral Solution
-
ANI Pharmaceuticals Appoints Peter A. Lankau to Its Board of Directors
-
ANI Pharmaceuticals Announces Board Authorization of Stock Repurchase Program
-
ANI Pharmaceuticals to Acquire Two NDAs from Merck for $75 Million
-
ANI Pharmaceuticals and IDT Australia Enter Partnership to Commercialize US Generic Drug Products
-
ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights
-
ANI Pharmaceuticals and Sofgen Announce FDA Approval of Nimodipine 30mg Capsules
-
ANI Pharmaceuticals Acquires 22 Generic Drug Products from Teva Pharmaceuticals for $25 million
-
ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL
-
ANI Pharmaceuticals Presents at the UBS Global Healthcare Conference
-
ANI Pharmaceuticals Acquires Rights to Testosterone Gel 1%
-
ANI Pharmaceuticals Reports First Quarter 2015 Financial Results
-
ANI Pharmaceuticals Presents At 14th Annual Needham Healthcare Conference
-
ANI Pharmaceuticals Announces the Launch of Propafenone Tablets
-
ANI Pharmaceuticals Announces the Launch of Etodolac 200mg Capsules
-
ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals

